Cui Dan, Liu Xinliang, Hawkey Peter, Li Hao, Wang Quan, Mao Zongfu, Sun Jing
1 School of Public Health, Global Health Institute, Wuhan University, China.
2 School of Biosciences, School of Immunity and Infection, University of Birmingham, Birmingham, UK.
J Int Med Res. 2017 Dec;45(6):1768-1778. doi: 10.1177/0300060516686230. Epub 2017 Jan 30.
We analyzed China's current use of and microbial resistance to antibiotics, and possible means of reducing antimicrobial resistance. Interventions like executive orders within clinical settings and educational approach with vertical approaches rather than an integrated strategy to curb the use of antimicrobials remain limited. An underlying problem is the system of incentives that has resulted in the intensification of inappropriate use by health professionals and patients. There is an urgent need to explore the relationship between financial and non-financial incentives for providers and patients, to eliminate inappropriate incentives. China's national health reforms have created an opportunity to contain inappropriate use of antibiotics through more comprehensive and integrated strategies. Containment of microbial resistance may be achieved by strengthening surveillance at national, regional and hospital levels; eliminating detrimental incentives within the health system; and changing prescribing behaviors to a wider health systems approach, to achieve long-term, equitable and sustainable results and coordinate stakeholders' actions through transparent sharing of information.
我们分析了中国目前抗生素的使用情况及微生物对抗生素的耐药性,以及降低抗菌药物耐药性的可能方法。诸如临床环境中的行政命令以及采用纵向方法而非综合策略来抑制抗菌药物使用的教育方法等干预措施仍然有限。一个根本问题是激励机制,它导致了医护人员和患者不当使用抗生素的情况加剧。迫切需要探索针对医护人员和患者的经济激励与非经济激励之间的关系,以消除不当激励。中国的国家卫生改革创造了一个机会,可通过更全面、综合的策略来遏制抗生素的不当使用。可通过加强国家、地区和医院层面的监测;消除卫生系统内的有害激励;将处方行为转变为更广泛的卫生系统方法,以实现长期、公平和可持续的成果,并通过透明的信息共享来协调利益相关者的行动,从而控制微生物耐药性。